## Abstract The transcription factor PAX3 is expressed during early embryogenesis and in multiple cancer types, including embryonal rhabdomyosarcoma (ERMS), Ewing sarcoma (ES) and malignant melanoma (MEL), suggesting that it could function as a general tumor associated antigen. Major histocompatibi
Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes
โ Scribed by Hub F. J. Dullens; Sjef Schakenraad; Ad Oostdijk; Wim Vuist; Martin Maas; Willem Otter
- Publisher
- Springer-Verlag
- Year
- 1986
- Tongue
- English
- Weight
- 795 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
โฆ Synopsis
The antitumor potency and specificity of syngeneic immune peritoneal exudate cells were tested. Groups of DBA/2 mice were immunized against syngeneic SL2 tumor cells. Then 6 days after the last immunization the antitumor potency, and the specificity of the immunization reaction was tested by (a) injecting groups of the immunized mice with l03 to 5 ร l 0 7 DBA/2 derived L1210, L5178Y, P815 or SL2 tumor cells, and (b) injecting immune peritoneal exudate cells into DBA/2 mice which had been injected 2 h earlier i. p. with 2 x 104 or 2 x 105 L1210, L5178Y, P815, or SL2 cells. Furthermore the tumor specific cytotoxicity in vitro of isolated immune (vs SL2) peritoneal macrophages was tested against L1210, L5178Y, P815, and SL2 cells. The "reciprocal" experiments (previous immunization against L1210, L5178Y, or P815 cells and 'challenge' with SL2) were also done. Finally, we tested the tumor-specific cytotoxicity of isolated immune peritoneal T-lymphocytes.
It was shown that (a) the rejection of tumor cells in previously immunized mice, (b) the antitumor efficacy of the transferred immune peritoneal exudate cells and (c) the in vitro cytotoxicity of purified immune peritoneal macrophages and lymphocytes, were tumor-specific reactions. That is only between the SL2 and L5178Y tumors were cross-reactions observed. However, this cross-reaction was not found at the level of cytotoxic T-cells. This suggests that cytotoxic T-cells and cytotoxic macrophages probably have different mechanisms of recognition of the specific tumor target cells.
Treatment of macrophage monolayers, prepared from macrophages of immunized mice, with monoclonal anti-Thy-1 antibodies plus complement caused no decrease in cytotoxicity. This shows that macrophages can really express specific cytotoxicity. Tumoricidal macrophages probably obtain their tumor specificity through the activities of tumor-specific factors produced by sensitized Tcells.
๐ SIMILAR VOLUMES
Prostate-specific antigen (PSA), a tissue-specific protein expressed by most adenocarcinomas of the prostate, might be a useful target for T-cell-mediated immunotherapy of prostate cancers. The current study examined whether it is possible to elicit human cytotoxic T lymphocytes (CTL) with specifici